Friday, 4 September 2026European Markets

NEURONES And CAPGEMINI Have A High Dividend Yield And Return On Equity In The Information Technology Services Industry.

Loading stream...

(vianews) - neurones (nro.pa) is among this list of stock assets with the highest dividend rate and return on equity on the information technology services industry.

financial asset price forward dividend yield return on equity
neurones (nro.pa) €39.45 2.82% 14.2%
capgemini (cap.pa) €175.80 1.85% 17.01%

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. neurones (nro.pa)

2.82% forward dividend yield and 14.2% return on equity

neurones s.a., an information technology (it) services company, provides infrastructure, application, and consulting services in france and internationally. its infrastructure services include infrastructure management, manages public and private cloud services, it operations, user support, devops, cybersecurity, it service management, information system governance, and automation. the company also provides application services in the areas of sap, digital, web, mobility, ux/ui, enterprise content and document management, business process management, robotic process automation, dematerialization, it consulting for finance, big data, and devops, it training and change management, and innovation connected devices (iot). in addition, it offers consulting services, including management and digital transformation, and digital marketing consulting; digital transformation services in the areas of agile/scrum, devops, ci/cd, cloud, infrastructure as code, cyber security, analytics, big data, mobility, digital workplace, connected devices, innovations, client experience, ux/ui, and digital marketing, as well as internal process digitization, ecm/bpm, rpa, dematerialization, ai, predictive maintenance, machine learning, and blockchain; and managed services/outsourcing services. the company serves banking/insurance, services/consumer goods, energy/utilities/healthcare, technologies/media/telecoms, industry/public works and civil engineering, and public sector markets. neurones s.a. was founded in 1984 and is based in nanterre, france.

earnings per share

as for profitability, neurones has a trailing twelve months eps of €1.83.

pe ratio

neurones has a trailing twelve months price to earnings ratio of 21.56. meaning, the purchaser of the share is investing €21.56 for every euro of annual earnings.

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 14.2%.

dividend yield

according to morningstar, inc., the next dividend payment is on jun 14, 2023, the estimated forward annual dividend rate is 1.1 and the estimated forward annual dividend yield is 2.82%.

volume

today's last reported volume for neurones is 2809 which is 1.19% below its average volume of 2843.

more news about neurones.

2. capgemini (cap.pa)

1.85% forward dividend yield and 17.01% return on equity

capgemini se provides consulting, digital transformation, technology, and engineering services primarily in the americas, europe, the middle east, africa, and the asia-pacific. the company offers strategy and transformation services, including strategy, technology, data science, and creative design to support various clients within the digital economy. it also provides applications and technology services that helps the clients to develop, modernize, extend, and secure their it and digital environment using the latest technologies, as well as offers local technology services in cloud, cybersecurity, quality assurance, testing, and new technology fields. in addition, the company offers business process outsourcing and transactional services, as well as installation and maintenance services for its clients' it infrastructures in data centers or in the cloud. it serves various industries, including consumer goods and retail; energy and utilities; banking, capital markets, and insurance; manufacturing and life sciences; public sector; telecommunications, media, and technology; and services. capgemini se has a strategic partnership with cona services llc to develop digital solutions for the consumer products industry and retail customers. the company was founded in 1967 and is headquartered in paris, france.

earnings per share

as for profitability, capgemini has a trailing twelve months eps of €8.79.

pe ratio

capgemini has a trailing twelve months price to earnings ratio of 20. meaning, the purchaser of the share is investing €20 for every euro of annual earnings.

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 17.01%.

volume

today's last reported volume for capgemini is 72252 which is 80.33% below its average volume of 367483.

moving average

capgemini's worth is above its 50-day moving average of €167.02 and higher than its 200-day moving average of €169.63.

revenue growth

year-on-year quarterly revenue growth grew by 19.7%, now sitting on 21.99b for the twelve trailing months.

more news about capgemini.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Funding Surge: Capital Floods Fintech, Foundation Models, and Autonomous Systems
A concentrated burst of AI-linked funding on 2026-08-28 pushed well over $1.5B into companies spanning fraud/identity fintech (Socure, which also acquired Fravity), foundation models (Stability AI), AI agents and enterprise tooling (Instinct, Generalist AI, Emerald AI, Owner), and AI-adjacent autonomous/aerospace ventures (Gatik, Regent Craft). The breadth and simultaneity of these rounds signal that investor appetite for AI is not concentrated in a single vertical but is broadening into applied and infrastructure-adjacent domains, with consolidation (Socure-Fravity) beginning alongside fresh capital formation.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Morgan Stanley & Co. LLC
The same metric (eps) for the same entity (Morgan Stanley & Co. LLC) reported for the identical fiscal period (Q1 2026) and observation date (2026-03-31) has two conflicting values: 3.43 USD_per_share vs 3.08 USD. This is not a temporal change — both observations claim to measure the same point in time. The ~10% discrepancy (0.35 USD difference) is material for a financial metric.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,269 source documents archived
Query this data → isubstrate.com